Correlation Between Dyadic International and Eterna Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dyadic International and Eterna Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyadic International and Eterna Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyadic International and Eterna Therapeutics, you can compare the effects of market volatilities on Dyadic International and Eterna Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyadic International with a short position of Eterna Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyadic International and Eterna Therapeutics.
Diversification Opportunities for Dyadic International and Eterna Therapeutics
-0.18 | Correlation Coefficient |
Good diversification
The 3 months correlation between Dyadic and Eterna is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Dyadic International and Eterna Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eterna Therapeutics and Dyadic International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyadic International are associated (or correlated) with Eterna Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eterna Therapeutics has no effect on the direction of Dyadic International i.e., Dyadic International and Eterna Therapeutics go up and down completely randomly.
Pair Corralation between Dyadic International and Eterna Therapeutics
Given the investment horizon of 90 days Dyadic International is expected to generate 0.68 times more return on investment than Eterna Therapeutics. However, Dyadic International is 1.46 times less risky than Eterna Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Eterna Therapeutics is currently generating about -0.04 per unit of risk. If you would invest 125.00 in Dyadic International on December 6, 2024 and sell it today you would earn a total of 25.00 from holding Dyadic International or generate 20.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Dyadic International vs. Eterna Therapeutics
Performance |
Timeline |
Dyadic International |
Eterna Therapeutics |
Dyadic International and Eterna Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Dyadic International and Eterna Therapeutics
The main advantage of trading using opposite Dyadic International and Eterna Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyadic International position performs unexpectedly, Eterna Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eterna Therapeutics will offset losses from the drop in Eterna Therapeutics' long position.Dyadic International vs. Werewolf Therapeutics | Dyadic International vs. Edgewise Therapeutics | Dyadic International vs. Celcuity LLC | Dyadic International vs. C4 Therapeutics |
Eterna Therapeutics vs. Arcus Biosciences | Eterna Therapeutics vs. Cullinan Oncology LLC | Eterna Therapeutics vs. Annexon | Eterna Therapeutics vs. Structure Therapeutics American |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Commodity Directory Find actively traded commodities issued by global exchanges |